| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 4.53e-09 | 7 | 69 | 4 | GO:0030628 | |
| GeneOntologyMolecularFunction | RS domain binding | 9.04e-09 | 8 | 69 | 4 | GO:0050733 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 8.73e-08 | 64 | 69 | 6 | GO:0036002 | |
| GeneOntologyMolecularFunction | mRNA binding | FXR1 SRSF3 SRSF4 TRA2B LUC7L3 CPSF6 LUC7L2 DDX23 SRRM3 CPSF7 | 1.29e-04 | 694 | 69 | 10 | GO:0003729 |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 6.34e-04 | 11 | 69 | 2 | GO:0099122 | |
| GeneOntologyBiologicalProcess | mRNA processing | SRRM1 SCAF1 U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 ZRSR2 CPSF6 CDK13 LUC7L2 RBMX2 DHX38 PHRF1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B SREK1 RBM23 RSRC1 SCAF4 SON CPSF7 SRSF12 | 1.16e-29 | 551 | 67 | 30 | GO:0006397 |
| GeneOntologyBiologicalProcess | RNA splicing | SRRM1 SCAF1 U2AF1 ZRSR2P1 PPIG SRSF10 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 ZRSR2 CLK2 CDK13 LUC7L2 RBMX2 CLK4 DHX38 CCNL1 DDX23 TRA2A U2AF2 SRSF11 PRPF38B SREK1 RBM23 RSRC1 SON SRSF12 | 2.39e-29 | 502 | 67 | 29 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | SRRM1 SCAF1 U2AF1 ZRSR2P1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 ZRSR2 CPSF6 CDK13 LUC7L2 RBMX2 DHX38 PHRF1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B SREK1 RBM23 RSRC1 SCAF4 SON CPSF7 SRSF12 | 1.93e-24 | 917 | 67 | 31 | GO:0016071 |
| GeneOntologyBiologicalProcess | RNA processing | SRRM1 SCAF1 U2AF1 ZRSR2P1 PPIG SRSF10 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 ZRSR2 CLK2 CPSF6 CDK13 LUC7L2 RBMX2 CLK4 DHX38 CCNL1 PHRF1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B SREK1 RBM23 RSRC1 SCAF4 SON CPSF7 SRSF12 | 1.87e-21 | 1500 | 67 | 34 | GO:0006396 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | SRRM1 U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 CDK13 LUC7L2 RBMX2 DHX38 DDX23 TRA2A U2AF2 RBM23 RSRC1 SON SRSF12 | 1.00e-19 | 358 | 67 | 20 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | SRRM1 U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 CDK13 LUC7L2 RBMX2 DHX38 DDX23 TRA2A U2AF2 RBM23 RSRC1 SON SRSF12 | 1.00e-19 | 358 | 67 | 20 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | SRRM1 U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 CDK13 LUC7L2 RBMX2 DHX38 DDX23 TRA2A U2AF2 RBM23 RSRC1 SON SRSF12 | 1.25e-19 | 362 | 67 | 20 | GO:0000375 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | SRRM1 SRSF10 SRSF3 SRSF4 TRA2B AKAP17A CLK2 CLK4 CCNL1 TRA2A U2AF2 RBM23 SON SRSF12 | 4.14e-15 | 207 | 67 | 14 | GO:0043484 |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | SRRM1 SRSF10 SRSF3 SRSF4 TRA2B TRA2A FIP1L1 U2AF2 RBM23 SON SRSF12 | 3.33e-12 | 158 | 67 | 11 | GO:0050684 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.18e-11 | 129 | 67 | 10 | GO:0048024 | |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 1.09e-09 | 99 | 67 | 8 | GO:0000245 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | SRRM1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B TRA2A FIP1L1 U2AF2 RBM23 SON SRSF12 | 1.71e-08 | 443 | 67 | 12 | GO:1903311 |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 1.22e-06 | 244 | 67 | 8 | GO:0022618 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 1.65e-06 | 254 | 67 | 8 | GO:0071826 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.96e-06 | 28 | 67 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 2.27e-06 | 29 | 67 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 3.88e-06 | 33 | 67 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 2.45e-05 | 52 | 67 | 4 | GO:0006376 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 3.62e-05 | 115 | 67 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.27e-04 | 79 | 67 | 4 | GO:0000380 | |
| GeneOntologyBiologicalProcess | mRNA alternative polyadenylation | 1.55e-04 | 6 | 67 | 2 | GO:0110104 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 2.56e-04 | 515 | 67 | 8 | GO:0022613 | |
| GeneOntologyBiologicalProcess | co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway | 3.69e-04 | 9 | 67 | 2 | GO:0180010 | |
| GeneOntologyBiologicalProcess | mRNA 3'-end processing | 4.50e-04 | 46 | 67 | 3 | GO:0031124 | |
| GeneOntologyBiologicalProcess | co-transcriptional RNA 3'-end processing, cleavage and polyadenylation pathway | 4.60e-04 | 10 | 67 | 2 | GO:0180012 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.13e-03 | 63 | 67 | 3 | GO:0033120 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 1.21e-03 | 16 | 67 | 2 | GO:0051290 | |
| GeneOntologyCellularComponent | nuclear speck | SRRM1 U2AF1 PPIG CACNB4 SRSF10 SRSF3 SRSF4 AKAP17A LUC7L3 CLK2 CPSF6 CDK13 BCLAF1 LUC7L2 CCNL1 U2AF2 SRSF11 SREK1 TOPORS RSRC1 SON SRSF12 | 8.07e-21 | 431 | 68 | 22 | GO:0016607 |
| GeneOntologyCellularComponent | spliceosomal complex | SRRM1 U2AF1 ZRSR2P1 TRA2B AKAP17A LUC7L3 ZRSR2 LUC7L2 RBMX2 DHX38 DDX23 TRA2A U2AF2 PRPF38B SREK1 | 2.56e-16 | 215 | 68 | 15 | GO:0005681 |
| GeneOntologyCellularComponent | nuclear body | SRRM1 U2AF1 PPIG CACNB4 SRSF10 SRSF3 SRSF4 AKAP17A LUC7L3 CLK2 CPSF6 CDK13 BCLAF1 LUC7L2 CCNL1 U2AF2 SRSF11 SREK1 TOPORS RSRC1 SON SRSF12 | 4.51e-14 | 903 | 68 | 22 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SRRM1 U2AF1 ZRSR2P1 TRA2B AKAP17A LUC7L3 ZRSR2 CPSF6 CDK13 BCLAF1 LUC7L2 RBMX2 DHX38 CCNL1 MEPCE DDX23 TRA2A FIP1L1 U2AF2 PRPF38B SREK1 CCDC9 CPSF7 | 2.56e-11 | 1377 | 68 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | U2AF complex | 3.56e-09 | 7 | 68 | 4 | GO:0089701 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | SRRM1 U2AF1 ZRSR2P1 SRSF4 TRA2B AKAP17A LUC7L3 ZRSR2 CPSF6 LUC7L2 RBMX2 DHX38 MEPCE DDX23 TRA2A U2AF2 PRPF38B SREK1 | 3.07e-08 | 1194 | 68 | 18 | GO:1990904 |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 2.58e-05 | 107 | 68 | 5 | GO:0030532 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 2.59e-05 | 18 | 68 | 3 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 2.59e-05 | 18 | 68 | 3 | GO:0071010 | |
| GeneOntologyCellularComponent | Sm-like protein family complex | 4.30e-05 | 119 | 68 | 5 | GO:0120114 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 8.11e-05 | 26 | 68 | 3 | GO:0005847 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 1.39e-04 | 31 | 68 | 3 | GO:0005849 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 2.72e-04 | 96 | 68 | 4 | GO:0097525 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 2.83e-04 | 97 | 68 | 4 | GO:0071013 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 2.83e-04 | 97 | 68 | 4 | GO:0005684 | |
| GeneOntologyCellularComponent | U12-type spliceosomal complex | 4.28e-03 | 30 | 68 | 2 | GO:0005689 | |
| Domain | RRM | U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B AKAP17A ZRSR2 CPSF6 RBMX2 TRA2A U2AF2 SRSF11 SREK1 RBM23 SCAF4 CPSF7 SRSF12 | 8.80e-20 | 230 | 66 | 18 | PS50102 |
| Domain | RRM_1 | U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B ZRSR2 CPSF6 RBMX2 TRA2A U2AF2 SRSF11 SREK1 RBM23 SCAF4 CPSF7 SRSF12 | 5.01e-19 | 208 | 66 | 17 | PF00076 |
| Domain | Nucleotide-bd_a/b_plait | U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B AKAP17A ZRSR2 CPSF6 RBMX2 TRA2A U2AF2 SRSF11 SREK1 RBM23 SCAF4 CPSF7 SRSF12 | 7.01e-19 | 258 | 66 | 18 | IPR012677 |
| Domain | RRM | U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B ZRSR2 CPSF6 RBMX2 TRA2A U2AF2 SRSF11 SREK1 RBM23 SCAF4 CPSF7 SRSF12 | 1.04e-18 | 217 | 66 | 17 | SM00360 |
| Domain | RRM_dom | U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B ZRSR2 CPSF6 RBMX2 TRA2A U2AF2 SRSF11 SREK1 RBM23 SCAF4 CPSF7 SRSF12 | 2.24e-18 | 227 | 66 | 17 | IPR000504 |
| Domain | - | SRSF10 SRSF3 SRSF4 TRA2B AKAP17A ZRSR2 CPSF6 RBMX2 TRA2A U2AF2 SRSF11 SREK1 RBM23 SCAF4 CPSF7 SRSF12 | 2.10e-16 | 244 | 66 | 16 | 3.30.70.330 |
| Domain | U2AF_small | 4.19e-07 | 5 | 66 | 3 | IPR009145 | |
| Domain | LUC7 | 3.68e-05 | 3 | 66 | 2 | PF03194 | |
| Domain | Luc7-rel | 3.68e-05 | 3 | 66 | 2 | IPR004882 | |
| Domain | ZnF_C3H1 | 6.51e-04 | 48 | 66 | 3 | SM00356 | |
| Domain | zf-CCCH | 6.91e-04 | 49 | 66 | 3 | PF00642 | |
| Domain | Znf_CCCH | 1.13e-03 | 58 | 66 | 3 | IPR000571 | |
| Domain | Cyclophilin-type_PPIase_CS | 2.02e-03 | 19 | 66 | 2 | IPR020892 | |
| Domain | Cyclophilin-type_PPIase | 2.47e-03 | 21 | 66 | 2 | IPR024936 | |
| Domain | Pro_isomerase | 2.71e-03 | 22 | 66 | 2 | PF00160 | |
| Domain | - | 2.71e-03 | 22 | 66 | 2 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 2.71e-03 | 22 | 66 | 2 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 2.71e-03 | 22 | 66 | 2 | IPR029000 | |
| Domain | CSA_PPIASE_1 | 2.71e-03 | 22 | 66 | 2 | PS00170 | |
| Domain | CSA_PPIASE_2 | 2.71e-03 | 22 | 66 | 2 | PS50072 | |
| Domain | G_patch | 2.97e-03 | 23 | 66 | 2 | SM00443 | |
| Domain | G_patch_dom | 2.97e-03 | 23 | 66 | 2 | IPR000467 | |
| Domain | G-patch | 2.97e-03 | 23 | 66 | 2 | PF01585 | |
| Domain | G_PATCH | 2.97e-03 | 23 | 66 | 2 | PS50174 | |
| Domain | CYCLIN | 7.97e-03 | 38 | 66 | 2 | SM00385 | |
| Domain | - | 8.80e-03 | 40 | 66 | 2 | 1.10.472.10 | |
| Domain | Cyclin-like | 1.01e-02 | 43 | 66 | 2 | IPR013763 | |
| Pathway | WP_MRNA_PROCESSING | SRRM1 U2AF1 ZRSR2P1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B AKAP17A ZRSR2 CLK2 BCLAF1 RBMX2 CLK4 DHX38 TTC14 U2AF2 SRSF11 SREK1 RSRC2 SON CPSF7 SRSF12 | 3.56e-21 | 451 | 52 | 23 | MM15946 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | SRRM1 U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 CPSF6 RBMX2 DHX38 DDX23 FIP1L1 U2AF2 SRSF11 CPSF7 SRSF12 | 3.78e-18 | 283 | 52 | 18 | M13087 |
| Pathway | REACTOME_MRNA_SPLICING | SRRM1 U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 RBMX2 DHX38 DDX23 U2AF2 SRSF11 SRSF12 | 7.59e-16 | 212 | 52 | 15 | M14033 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | SRRM1 U2AF1 ZRSR2P1 SRSF10 SRSF3 TRA2B LUC7L3 ZRSR2 CPSF6 RBMX2 DHX38 DDX23 FIP1L1 U2AF2 SRSF11 CPSF7 | 1.76e-15 | 277 | 52 | 16 | MM15414 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | SRRM1 U2AF1 SRSF3 SRSF4 CPSF6 DHX38 FIP1L1 U2AF2 SRSF11 CPSF7 | 3.95e-14 | 67 | 52 | 10 | M27694 |
| Pathway | REACTOME_MRNA_SPLICING | SRRM1 U2AF1 ZRSR2P1 SRSF10 SRSF3 TRA2B LUC7L3 ZRSR2 RBMX2 DHX38 DDX23 U2AF2 SRSF11 | 2.66e-13 | 201 | 52 | 13 | MM15411 |
| Pathway | WP_MRNA_PROCESSING | SRRM1 U2AF1 SRSF10 SRSF3 SRSF4 TRA2B CLK2 CLK4 DHX38 U2AF2 SREK1 | 8.27e-13 | 126 | 52 | 11 | M39406 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.07e-12 | 62 | 52 | 9 | MM15426 | |
| Pathway | KEGG_SPLICEOSOME | U2AF1 SRSF10 SRSF3 SRSF4 TRA2B DHX38 DDX23 TRA2A U2AF2 PRPF38B | 2.83e-11 | 127 | 52 | 10 | M2044 |
| Pathway | REACTOME_METABOLISM_OF_RNA | SRRM1 U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 CPSF6 RBMX2 DHX38 DDX23 FIP1L1 U2AF2 SRSF11 CPSF7 SRSF12 | 4.13e-11 | 724 | 52 | 18 | M16843 |
| Pathway | REACTOME_METABOLISM_OF_RNA | SRRM1 U2AF1 ZRSR2P1 SRSF10 SRSF3 TRA2B LUC7L3 ZRSR2 CPSF6 RBMX2 DHX38 DDX23 FIP1L1 U2AF2 SRSF11 CPSF7 | 3.17e-10 | 612 | 52 | 16 | MM15547 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.88e-10 | 84 | 52 | 8 | M725 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.63e-08 | 86 | 52 | 7 | MM15413 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 5.16e-05 | 20 | 52 | 3 | MM15469 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 5.16e-05 | 20 | 52 | 3 | M497 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 7.96e-05 | 23 | 52 | 3 | M41817 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.03e-04 | 25 | 52 | 3 | MM15608 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.62e-04 | 29 | 52 | 3 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.62e-04 | 29 | 52 | 3 | MM15444 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 2.85e-04 | 35 | 52 | 3 | M41738 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 3.37e-04 | 37 | 52 | 3 | MM15683 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 7.28e-04 | 48 | 52 | 3 | MM15410 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | SRRM1 U2AF1 SRSF3 PHF20L1 CPSF6 CDK13 DHX38 FIP1L1 U2AF2 SRSF11 CPSF7 | 1.06e-03 | 1022 | 52 | 11 | MM15436 |
| Pathway | WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION | 2.94e-03 | 22 | 52 | 2 | M48101 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 3.21e-03 | 23 | 52 | 2 | M41723 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 3.79e-03 | 25 | 52 | 2 | MM15606 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | SRRM1 U2AF1 SRSF3 SRSF4 CPSF6 CDK13 RBL2 DHX38 FIP1L1 U2AF2 SRSF11 CPSF7 | 3.91e-03 | 1387 | 52 | 12 | M734 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CEP350 SRRM1 U2AF1 SETD2 PPIG SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 CLK2 CPSF6 CDK13 RBL2 BCLAF1 LUC7L2 CLK4 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SREK1 GPATCH8 RSRC2 RBM23 RSRC1 SON SRSF12 | 1.47e-32 | 695 | 70 | 30 | 23602568 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SRRM1 U2AF1 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 CPSF6 CDK13 BCLAF1 LUC7L2 DHX38 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SRSF11 SREK1 GPATCH8 RSRC2 CCDC9 SCAF4 SON CPSF7 SRSF12 | 4.01e-29 | 807 | 70 | 29 | 22681889 |
| Pubmed | SRRM1 U2AF1 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B LUC7L3 CPSF6 BCLAF1 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B NKTR SREK1 GPATCH8 RSRC2 RSRC1 SCAF4 SON CPSF7 SRSF12 | 1.28e-27 | 713 | 70 | 27 | 29802200 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZNF8 SRRM1 U2AF1 SETD2 PPIG SRSF10 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 ZRSR2 CPSF6 BCLAF1 LUC7L2 RBMX2 PTDSS1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B SREK1 GPATCH8 RSRC2 SCAF4 SON CPSF7 | 1.63e-25 | 1082 | 70 | 29 | 38697112 |
| Pubmed | SCAF1 ZRSR2P1 PPIG SRSF4 TRA2B AKAP17A LUC7L3 CLK2 CPSF6 BCLAF1 RBMX2 DDX23 TRA2A FIP1L1 PRPF38B SCAF4 CPSF7 SRSF12 | 2.53e-23 | 251 | 70 | 18 | 31076518 | |
| Pubmed | SRRM1 U2AF1 SRSF10 SRSF4 AKAP17A LUC7L3 LUC7L2 CCNL1 PTDSS1 TRA2A U2AF2 PRPF38B SREK1 SON | 3.10e-22 | 104 | 70 | 14 | 31365120 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRRM1 SCAF1 U2AF1 SETD2 PPIG SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 CDK13 BCLAF1 LUC7L2 RBMX2 C16orf87 DHX38 PHRF1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 NKTR GPATCH8 RSRC1 SCAF4 SON CPSF7 | 4.45e-22 | 1294 | 70 | 28 | 30804502 |
| Pubmed | CEP350 SRRM1 SCAF1 U2AF1 PPIG SRSF10 FXR1 AKAP17A LUC7L3 CPSF6 CDK13 BCLAF1 LUC7L2 RBMX2 LAD1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B NKTR RSRC2 RBM23 RSRC1 SCAF4 SON CPSF7 | 2.08e-21 | 1371 | 70 | 28 | 36244648 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SRRM1 SCAF1 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 CLK2 CPSF6 LUC7L2 RBMX2 DHX38 PTDSS1 MEPCE DDX23 TRA2A U2AF2 SRSF11 PRPF38B NKTR SREK1 RSRC1 SON | 1.96e-19 | 1318 | 70 | 26 | 30463901 |
| Pubmed | SRRM1 U2AF1 ZRSR2P1 SRSF10 FXR1 SRSF4 TRA2B AKAP17A ZRSR2 RBMX2 TRA2A U2AF2 SRSF11 SREK1 SCAF4 SON CPSF7 | 3.17e-19 | 347 | 70 | 17 | 16033648 | |
| Pubmed | U2AF1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B ZRSR2 CLK2 CPSF6 CDK13 LUC7L2 DDX23 FIP1L1 U2AF2 SRSF11 PRPF38B SREK1 SRRM3 CCDC9 CPSF7 SRSF12 | 5.26e-19 | 723 | 70 | 21 | 34133714 | |
| Pubmed | SRRM1 U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 BCLAF1 LUC7L2 RBMX2 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B RSRC2 RSRC1 SON SRSF12 | 6.58e-19 | 731 | 70 | 21 | 29298432 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | SRRM1 U2AF1 PPIG SRSF3 SRSF4 AKAP17A LUC7L3 CLK2 LUC7L2 CCNL1 PTDSS1 U2AF2 SRSF11 PRPF38B SREK1 | 7.07e-18 | 269 | 70 | 15 | 29511261 |
| Pubmed | SRRM1 U2AF1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B LUC7L3 BCLAF1 LUC7L2 DHX38 PTDSS1 MEPCE TRA2A FIP1L1 U2AF2 SRSF11 SREK1 RSRC1 SON CPSF7 | 1.29e-17 | 847 | 70 | 21 | 35850772 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | SRRM1 SCAF1 PPIG SRSF4 TRA2B CDK13 BCLAF1 LUC7L2 RBMX2 PHRF1 TRA2A FIP1L1 NKTR SON | 1.51e-16 | 259 | 70 | 14 | 30404004 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SCAF1 U2AF1 SRSF10 SRSF3 TRA2B LUC7L3 CPSF6 BCLAF1 LUC7L2 DHX38 TTC14 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SRSF11 SREK1 GPATCH8 SON CPSF7 | 2.85e-16 | 989 | 70 | 21 | 36424410 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SRRM1 U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B TIAM1 AKAP17A LUC7L3 CLK2 CPSF6 BCLAF1 LUC7L2 DHX38 DDX23 U2AF2 SRSF11 PRPF38B SREK1 GPATCH8 SON | 3.99e-15 | 1284 | 70 | 22 | 17353931 |
| Pubmed | SRRM1 PPIG SRSF10 SRSF3 TRA2B TIAM1 LUC7L3 CLK2 BCLAF1 LUC7L2 TRA2A PRPF38B SON | 4.26e-15 | 255 | 70 | 13 | 15324660 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B RBMX2 DHX38 TTC14 TRA2A U2AF2 RBM23 | 6.21e-15 | 197 | 70 | 12 | 22365833 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | CEP350 SRRM1 U2AF1 SRSF10 SRSF4 TRA2B LUC7L3 CPSF6 CDK13 BCLAF1 LUC7L2 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SCAF4 | 1.73e-14 | 670 | 70 | 17 | 22990118 |
| Pubmed | Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. | 2.45e-14 | 11 | 70 | 6 | 14729963 | |
| Pubmed | SRRM1 U2AF1 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B CPSF6 BCLAF1 LUC7L2 LAD1 MEPCE FIP1L1 U2AF2 SRSF11 PRPF38B RSRC2 TOPORS CCDC9 CPSF7 | 2.71e-14 | 1247 | 70 | 21 | 27684187 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CEP350 SRRM1 SCAF1 U2AF1 SRSF10 FXR1 SRSF3 TRA2B LUC7L3 CPSF6 BCLAF1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 SCAF4 SON CPSF7 | 1.06e-13 | 1024 | 70 | 19 | 24711643 |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | SCAF1 PPIG SRSF10 FXR1 SRSF4 TRA2B LUC7L3 BCLAF1 RBMX2 TRA2A NKTR SON SRSF12 | 1.17e-13 | 330 | 70 | 13 | 33301849 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 SCAF1 SETD2 PPIG SRSF10 CDK13 BCLAF1 RBMX2 CCNL1 PHRF1 FIP1L1 PRPF38B GPATCH8 TOPORS CCDC9 SCAF4 SON | 1.78e-13 | 774 | 70 | 17 | 15302935 |
| Pubmed | SRRM1 U2AF1 PPIG FXR1 SRSF3 TRA2B LUC7L3 CDK13 RBL2 BCLAF1 LUC7L2 MEPCE DDX23 U2AF2 SRSF11 SREK1 | 2.02e-13 | 655 | 70 | 16 | 35819319 | |
| Pubmed | U2AF1 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B AKAP17A LUC7L2 TRA2A U2AF2 | 3.27e-13 | 203 | 70 | 11 | 35012549 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | SRRM1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B LUC7L3 CPSF6 CDK13 BCLAF1 LUC7L2 FIP1L1 U2AF2 SRSF11 SREK1 SON | 3.42e-13 | 678 | 70 | 16 | 30209976 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | SRRM1 SCAF1 PPIG SRSF3 TRA2B CDK13 BCLAF1 TRA2A FIP1L1 SRSF11 PRPF38B SON CPSF7 | 3.65e-13 | 361 | 70 | 13 | 26167880 |
| Pubmed | SRRM1 SRSF10 SRSF3 TRA2B CPSF6 TRA2A U2AF2 SRSF11 SREK1 CPSF7 | 6.38e-13 | 153 | 70 | 10 | 28225217 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | U2AF1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B CPSF6 BCLAF1 DHX38 DDX23 TRA2A U2AF2 SRSF11 GPATCH8 RBM23 SON | 7.48e-13 | 714 | 70 | 16 | 28302793 |
| Pubmed | 1.16e-12 | 109 | 70 | 9 | 12226669 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SRRM1 U2AF1 FXR1 TRA2B AKAP17A LUC7L3 CPSF6 CDK13 BCLAF1 LUC7L2 RBMX2 PTDSS1 MEPCE DDX23 FIP1L1 U2AF2 SON | 4.54e-12 | 949 | 70 | 17 | 36574265 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRRM1 U2AF1 SETD2 SRSF10 SRSF3 SRSF4 LUC7L3 CPSF6 BCLAF1 FIP1L1 U2AF2 SRSF11 SREK1 SCAF4 SON CPSF7 SRSF12 | 4.93e-12 | 954 | 70 | 17 | 36373674 |
| Pubmed | SCAF1 SETD2 SRSF10 AKAP17A CPSF6 CDK13 RBMX2 CLK4 DHX38 CCNL1 PHRF1 PTDSS1 PRPF38B SREK1 GPATCH8 RSRC2 RBM23 RSRC1 SCAF4 SON | 8.69e-12 | 1497 | 70 | 20 | 31527615 | |
| Pubmed | U2AF1 SRSF3 LUC7L3 CPSF6 LUC7L2 U2AF2 SRSF11 PRPF38B SREK1 RSRC1 | 1.24e-11 | 206 | 70 | 10 | 34185411 | |
| Pubmed | SRRM1 SCAF1 SRSF4 LUC7L2 DHX38 DDX23 U2AF2 SRSF11 PRPF38B SREK1 GPATCH8 | 2.26e-11 | 300 | 70 | 11 | 28561026 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.67e-11 | 154 | 70 | 9 | 16055720 | |
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 3.63e-11 | 13 | 70 | 5 | 20516191 | |
| Pubmed | FXR1 SRSF4 TRA2B CPSF6 DHX38 MEPCE DDX23 TRA2A FIP1L1 U2AF2 RBM23 CCDC9 SCAF4 CPSF7 | 4.33e-11 | 653 | 70 | 14 | 33742100 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 4.45e-11 | 163 | 70 | 9 | 22113938 | |
| Pubmed | 5.38e-11 | 239 | 70 | 10 | 26641092 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SRRM1 U2AF1 PPIG SRSF10 FXR1 SRSF3 TRA2B CPSF6 CDK13 BCLAF1 LUC7L2 U2AF2 GPATCH8 RSRC1 | 5.50e-11 | 665 | 70 | 14 | 30457570 |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 6.15e-11 | 169 | 70 | 9 | 23084401 | |
| Pubmed | SRSF3 SRSF4 TRA2B BCLAF1 MEPCE DDX23 TRA2A U2AF2 GPATCH8 RSRC1 | 6.59e-11 | 244 | 70 | 10 | 29884807 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SRRM1 U2AF1 SRSF3 SRSF4 LUC7L3 CPSF6 LUC7L2 DDX23 FIP1L1 U2AF2 SRSF11 SREK1 CPSF7 | 1.40e-10 | 582 | 70 | 13 | 20467437 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | SRRM1 U2AF1 FXR1 SRSF4 LUC7L3 CPSF6 BCLAF1 LUC7L2 RBMX2 PTDSS1 U2AF2 GPATCH8 | 2.47e-10 | 486 | 70 | 12 | 30940648 |
| Pubmed | 5.24e-10 | 7 | 70 | 4 | 9237760 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SRRM1 TRA2B AKAP17A LUC7L3 CDK13 BCLAF1 DHX38 U2AF2 SRSF11 GPATCH8 RSRC2 | 7.99e-10 | 420 | 70 | 11 | 28065597 |
| Pubmed | U2AF1 SETD2 SRSF10 FXR1 SRSF3 TRA2B LUC7L3 CPSF6 TRA2A U2AF2 CPSF7 | 8.19e-10 | 421 | 70 | 11 | 34650049 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 1.02e-09 | 96 | 70 | 7 | 25948554 | |
| Pubmed | SRRM1 SETD2 PPIG TRA2B CDK13 BCLAF1 DHX38 MEPCE DDX23 TRA2A FIP1L1 PRPF38B GPATCH8 SON CPSF7 | 1.36e-09 | 1014 | 70 | 15 | 32416067 | |
| Pubmed | 1.79e-09 | 57 | 70 | 6 | 21555454 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.59e-09 | 258 | 70 | 9 | 37794589 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | SRRM1 SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 BCLAF1 TRA2A FIP1L1 SON | 2.93e-09 | 361 | 70 | 10 | 30344098 |
| Pubmed | 3.63e-09 | 115 | 70 | 7 | 17332742 | ||
| Pubmed | 4.45e-09 | 188 | 70 | 8 | 29721183 | ||
| Pubmed | 4.91e-09 | 11 | 70 | 4 | 9472028 | ||
| Pubmed | ZNF8 SRRM1 SCAF1 SETD2 FXR1 AKAP17A LUC7L2 PHRF1 MEPCE FIP1L1 U2AF2 SREK1 RSRC2 TOPORS SON | 4.96e-09 | 1116 | 70 | 15 | 31753913 | |
| Pubmed | SRRM1 U2AF1 CPSF6 CDK13 BCLAF1 MEPCE DDX23 SRSF11 SCAF4 SON CPSF7 | 5.54e-09 | 506 | 70 | 11 | 30890647 | |
| Pubmed | A novel SR-related protein is required for the second step of Pre-mRNA splicing. | 7.36e-09 | 12 | 70 | 4 | 15798186 | |
| Pubmed | SRRM1 U2AF1 PPIG SRSF10 FXR1 SRSF4 TRA2B BCLAF1 DDX23 TRA2A U2AF2 SRSF11 | 7.70e-09 | 660 | 70 | 12 | 32780723 | |
| Pubmed | Nucleocytoplasmic shuttling of heterodimeric splicing factor U2AF. | 7.81e-09 | 3 | 70 | 3 | 11118443 | |
| Pubmed | 8.17e-09 | 73 | 70 | 6 | 22094256 | ||
| Pubmed | SRRM1 U2AF1 SRSF3 TRA2B PHRF1 TRA2A U2AF2 SRSF11 GPATCH8 CPSF7 | 1.38e-08 | 425 | 70 | 10 | 24999758 | |
| Pubmed | An interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineries. | 3.12e-08 | 4 | 70 | 3 | 17024186 | |
| Pubmed | Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. | 3.12e-08 | 4 | 70 | 3 | 14765198 | |
| Pubmed | Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation. | 3.12e-08 | 4 | 70 | 3 | 29276085 | |
| Pubmed | Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. | 3.12e-08 | 4 | 70 | 3 | 19574390 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SRRM1 U2AF1 SRSF3 TRA2B LUC7L3 BCLAF1 LUC7L2 DHX38 DDX23 FIP1L1 U2AF2 | 3.45e-08 | 605 | 70 | 11 | 28977666 |
| Pubmed | 3.51e-08 | 17 | 70 | 4 | 11060040 | ||
| Pubmed | 5.70e-08 | 19 | 70 | 4 | 25263594 | ||
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 8.22e-08 | 107 | 70 | 6 | 20508642 | |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 1.10e-07 | 57 | 70 | 5 | 14559993 | |
| Pubmed | 1.10e-07 | 399 | 70 | 9 | 35987950 | ||
| Pubmed | 1.20e-07 | 114 | 70 | 6 | 31553912 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SCAF1 U2AF1 SRSF10 FXR1 SRSF3 TRA2B LUC7L3 CPSF6 BCLAF1 LUC7L2 DHX38 TRA2A U2AF2 SREK1 CPSF7 | 1.24e-07 | 1425 | 70 | 15 | 30948266 |
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 1.43e-07 | 60 | 70 | 5 | 29055695 | |
| Pubmed | Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. | 1.55e-07 | 6 | 70 | 3 | 17361132 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | U2AF1 SRSF10 FXR1 SRSF3 TRA2B CPSF6 BCLAF1 DHX38 LAD1 MEPCE TRA2A U2AF2 TOPORS CPSF7 | 1.76e-07 | 1257 | 70 | 14 | 36526897 |
| Pubmed | U2AF1 SRSF10 FXR1 SRSF3 LUC7L3 CPSF6 LUC7L2 PTDSS1 U2AF2 SRSF11 SON | 2.12e-07 | 725 | 70 | 11 | 27025967 | |
| Pubmed | 2.56e-07 | 441 | 70 | 9 | 31239290 | ||
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 15169763 | ||
| Pubmed | Functional properties of p54, a novel SR protein active in constitutive and alternative splicing. | 2.72e-07 | 7 | 70 | 3 | 8816452 | |
| Pubmed | Sip1, a novel RS domain-containing protein essential for pre-mRNA splicing. | 2.72e-07 | 7 | 70 | 3 | 9447963 | |
| Pubmed | 3.15e-07 | 220 | 70 | 7 | 24550385 | ||
| Pubmed | SRRM1 SCAF1 SETD2 FXR1 CDK13 RBL2 DHX38 PTDSS1 TRA2A PRPF38B NKTR SREK1 GPATCH8 CPSF7 | 3.39e-07 | 1327 | 70 | 14 | 32694731 | |
| Pubmed | 3.66e-07 | 333 | 70 | 8 | 36779763 | ||
| Pubmed | 3.72e-07 | 138 | 70 | 6 | 30320910 | ||
| Pubmed | CEP350 SCAF1 SETD2 SRSF3 CPSF6 U2AF2 GPATCH8 RSRC2 WNK2 CPSF7 | 3.83e-07 | 608 | 70 | 10 | 16713569 | |
| Pubmed | U2AF1 SRSF10 FXR1 SRSF3 LUC7L3 CPSF6 TRA2A FIP1L1 U2AF2 CPSF7 | 4.25e-07 | 615 | 70 | 10 | 31048545 | |
| Pubmed | Spatial mapping of splicing factor complexes involved in exon and intron definition. | 4.34e-07 | 8 | 70 | 3 | 18559666 | |
| Pubmed | SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. | 4.34e-07 | 8 | 70 | 3 | 9671816 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 5.62e-07 | 148 | 70 | 6 | 32538781 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 5.68e-07 | 353 | 70 | 8 | 27545878 | |
| Pubmed | 5.81e-07 | 241 | 70 | 7 | 23125841 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 6.31e-07 | 358 | 70 | 8 | 32460013 | |
| Pubmed | 6.49e-07 | 245 | 70 | 7 | 35652658 | ||
| Pubmed | 6.50e-07 | 9 | 70 | 3 | 19857271 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SRRM1 U2AF1 FXR1 SRSF3 LUC7L3 CPSF6 CDK13 LUC7L2 DHX38 PTDSS1 DDX23 U2AF2 RSRC1 SON | 7.30e-07 | 1415 | 70 | 14 | 28515276 |
| Interaction | JMJD6 interactions | SCAF1 U2AF1 ZRSR2P1 SETD2 PPIG TRA2B AKAP17A LUC7L3 ZRSR2 CPSF6 LUC7L2 RBMX2 CLK4 DHX38 CCNL1 PHRF1 U2AF2 SRSF11 PRPF38B SREK1 RSRC2 RBM23 RSRC1 SCAF4 SON CPSF7 | 2.31e-34 | 205 | 70 | 26 | int:JMJD6 |
| Interaction | SRPK2 interactions | SRRM1 SCAF1 U2AF1 SETD2 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 ZRSR2 CLK2 CPSF6 CDK13 BCLAF1 LUC7L2 RBMX2 PTDSS1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B NKTR SREK1 GPATCH8 RSRC2 RBM23 RSRC1 SCAF4 SON CPSF7 SRSF12 | 1.03e-33 | 717 | 70 | 36 | int:SRPK2 |
| Interaction | RNPS1 interactions | SRRM1 U2AF1 SETD2 PPIG RIN3 SRSF10 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 CLK2 CPSF6 LUC7L2 DHX38 CCNL1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 NKTR SREK1 GPATCH8 TOPORS CCDC9 SCAF4 SON CPSF7 | 1.77e-30 | 425 | 70 | 29 | int:RNPS1 |
| Interaction | SRSF6 interactions | SRRM1 SCAF1 SETD2 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B AKAP17A CLK2 CPSF6 CDK13 BCLAF1 LUC7L2 CLK4 PHRF1 MEPCE DDX23 TRA2A U2AF2 SRSF11 PRPF38B NKTR SREK1 GPATCH8 TOPORS RBM23 SON SRSF12 | 7.70e-30 | 503 | 70 | 30 | int:SRSF6 |
| Interaction | CLK2 interactions | SRRM1 U2AF1 SETD2 SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 CLK2 CPSF6 BCLAF1 LUC7L2 MEPCE TRA2A FIP1L1 U2AF2 SRSF11 NKTR GPATCH8 SON CPSF7 SRSF12 | 1.50e-29 | 195 | 70 | 23 | int:CLK2 |
| Interaction | SRSF4 interactions | SRRM1 SCAF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B AKAP17A CLK2 CDK13 CLK4 MEPCE DDX23 TRA2A U2AF2 SRSF11 NKTR SREK1 GPATCH8 TOPORS RBM23 SON CPSF7 SRSF12 | 1.05e-26 | 300 | 70 | 24 | int:SRSF4 |
| Interaction | DDX23 interactions | SRRM1 SCAF1 U2AF1 SETD2 PPIG SRSF10 SRSF4 AKAP17A LUC7L3 CPSF6 CDK13 BCLAF1 RBMX2 DHX38 PHRF1 TTC14 MEPCE DDX23 FIP1L1 U2AF2 SRSF11 NKTR SREK1 GPATCH8 RSRC2 RSRC1 | 1.37e-24 | 480 | 70 | 26 | int:DDX23 |
| Interaction | SRSF1 interactions | SRRM1 SCAF1 U2AF1 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 ZRSR2 CLK2 CPSF6 CDK13 LUC7L2 RBMX2 CLK4 MEPCE TRA2A U2AF2 SRSF11 SREK1 RSRC1 SON CPSF7 SRSF12 | 4.96e-24 | 570 | 70 | 27 | int:SRSF1 |
| Interaction | SNRNP70 interactions | SRRM1 SCAF1 U2AF1 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B TIAM1 LUC7L3 CLK2 CPSF6 BCLAF1 LUC7L2 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B NKTR SREK1 GPATCH8 RSRC2 CCDC9 RSRC1 SCAF4 SON CPSF7 SRSF12 | 9.79e-24 | 984 | 70 | 32 | int:SNRNP70 |
| Interaction | SRRM4 interactions | SRRM1 U2AF1 ZRSR2P1 SRSF4 AKAP17A ZRSR2 LUC7L2 RBMX2 CLK4 C16orf87 SRSF11 SREK1 RSRC1 | 1.10e-23 | 37 | 70 | 13 | int:SRRM4 |
| Interaction | SAP18 interactions | SRRM1 SCAF1 U2AF1 SETD2 PPIG SRSF10 SRSF3 TRA2B CLK2 CPSF6 PHRF1 DDX23 TRA2A U2AF2 SRSF11 PRPF38B NKTR SREK1 GPATCH8 TOPORS CCDC9 SON | 1.90e-23 | 305 | 70 | 22 | int:SAP18 |
| Interaction | SRSF7 interactions | SRRM1 SCAF1 U2AF1 PPIG RIN3 SRSF10 FXR1 SRSF3 SRSF4 TRA2B LUC7L3 CLK2 CPSF6 BCLAF1 LUC7L2 MEPCE DDX23 TRA2A U2AF2 SRSF11 NKTR SREK1 CCDC9 SON | 4.52e-23 | 425 | 70 | 24 | int:SRSF7 |
| Interaction | LUC7L interactions | SRRM1 SETD2 PPIG SRSF10 FXR1 LUC7L3 CLK2 BCLAF1 LUC7L2 MEPCE TRA2A U2AF2 SRSF11 PRPF38B NKTR GPATCH8 RBM23 RSRC1 SCAF4 CPSF7 | 1.67e-22 | 242 | 70 | 20 | int:LUC7L |
| Interaction | DHX8 interactions | SRRM1 SCAF1 SETD2 SRSF4 AKAP17A LUC7L3 CPSF6 CDK13 BCLAF1 LUC7L2 RBMX2 DHX38 PHRF1 TTC14 DDX23 FIP1L1 SRSF11 NKTR GPATCH8 RSRC2 SON | 2.38e-22 | 292 | 70 | 21 | int:DHX8 |
| Interaction | SRPK1 interactions | SRRM1 U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 CPSF6 BCLAF1 LUC7L2 RBMX2 CLK4 PTDSS1 DDX23 U2AF2 SRSF11 SREK1 RSRC2 RBM23 RSRC1 SON SRSF12 | 6.91e-22 | 477 | 70 | 24 | int:SRPK1 |
| Interaction | SRSF11 interactions | SRRM1 PPIG SRSF10 SRSF3 SRSF4 TRA2B CLK2 BCLAF1 LUC7L2 DDX23 TRA2A U2AF2 SRSF11 PRPF38B SREK1 GPATCH8 SON SRSF12 | 7.78e-21 | 203 | 70 | 18 | int:SRSF11 |
| Interaction | PNN interactions | SRRM1 SCAF1 PPIG SRSF10 SRSF3 SRSF4 AKAP17A CLK2 CPSF6 BCLAF1 LUC7L2 RBMX2 DDX23 TRA2A U2AF2 SRSF11 NKTR SREK1 TOPORS CCDC9 | 1.43e-20 | 302 | 70 | 20 | int:PNN |
| Interaction | SNIP1 interactions | SRRM1 SCAF1 PPIG SRSF10 SRSF4 TRA2B CLK2 CDK13 BCLAF1 LUC7L2 RBMX2 PHRF1 TTC14 MEPCE TRA2A FIP1L1 NKTR GPATCH8 TOPORS CCDC9 SON SRSF12 | 1.76e-20 | 417 | 70 | 22 | int:SNIP1 |
| Interaction | CLK3 interactions | SRRM1 PPIG SRSF10 SRSF3 SRSF4 TRA2B CLK2 BCLAF1 LUC7L2 MEPCE TRA2A U2AF2 SRSF11 PRPF38B GPATCH8 TOPORS CCDC9 SRSF12 | 3.37e-20 | 220 | 70 | 18 | int:CLK3 |
| Interaction | ZC3H18 interactions | SRRM1 U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 CLK2 CPSF6 BCLAF1 LUC7L2 RBMX2 CLK4 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B NKTR RSRC2 TOPORS RSRC1 SON SRSF12 | 3.63e-19 | 877 | 70 | 27 | int:ZC3H18 |
| Interaction | MECP2 interactions | ZNF8 SRRM1 U2AF1 SETD2 PPIG SRSF10 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 ZRSR2 CPSF6 BCLAF1 LUC7L2 RBMX2 PTDSS1 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B NKTR SREK1 GPATCH8 RSRC2 SCAF4 SON CPSF7 | 4.09e-19 | 1287 | 70 | 31 | int:MECP2 |
| Interaction | SNRNP40 interactions | SRRM1 SCAF1 SETD2 SRSF10 SRSF3 PHF20L1 AKAP17A LUC7L3 CPSF6 BCLAF1 DHX38 PHRF1 TTC14 MEPCE DDX23 U2AF2 NKTR SREK1 GPATCH8 RSRC1 SCAF4 SON CPSF7 | 9.42e-18 | 637 | 70 | 23 | int:SNRNP40 |
| Interaction | RBM39 interactions | SRRM1 U2AF1 SETD2 PPIG RIN3 SRSF10 FXR1 SRSF3 SRSF4 TRA2B CLK2 CPSF6 BCLAF1 LUC7L2 DHX38 TTC14 MEPCE DDX23 TRA2A U2AF2 SRSF11 NKTR SREK1 GPATCH8 RBM23 RSRC1 SON | 2.85e-17 | 1042 | 70 | 27 | int:RBM39 |
| Interaction | SRPK3 interactions | SRRM1 U2AF1 SRSF3 SRSF4 LUC7L3 CLK2 CDK13 LUC7L2 TRA2A U2AF2 SRSF11 SREK1 RBM23 SCAF4 SON | 1.08e-16 | 190 | 70 | 15 | int:SRPK3 |
| Interaction | LUC7L2 interactions | U2AF1 SRSF10 FXR1 TRA2B LUC7L3 ZRSR2 CLK2 CPSF6 BCLAF1 LUC7L2 MEPCE TRA2A U2AF2 SRSF11 SREK1 GPATCH8 CCDC9 SRSF12 | 1.59e-16 | 353 | 70 | 18 | int:LUC7L2 |
| Interaction | U2AF2 interactions | SRRM1 SCAF1 U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B ZRSR2 CLK2 CPSF6 BCLAF1 LUC7L2 DDX23 TRA2A U2AF2 SRSF11 NKTR GPATCH8 SON CPSF7 SRSF12 | 2.26e-16 | 651 | 70 | 22 | int:U2AF2 |
| Interaction | NKAPD1 interactions | SRRM1 SCAF1 PPIG SRSF10 SRSF4 TRA2B CLK2 BCLAF1 CCNL1 DDX23 TRA2A U2AF2 NKTR CCDC9 | 3.19e-16 | 161 | 70 | 14 | int:NKAPD1 |
| Interaction | PRPF40A interactions | SRRM1 U2AF1 PPIG SRSF10 CPSF6 CDK13 RBMX2 CCNL1 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SRSF11 SREK1 CCDC9 SCAF4 SON CPSF7 | 5.52e-16 | 446 | 70 | 19 | int:PRPF40A |
| Interaction | CPSF6 interactions | SRRM1 SETD2 PPIG SRSF10 FXR1 TRA2B AKAP17A CLK2 CPSF6 BCLAF1 LUC7L2 MEPCE DDX23 TRA2A FIP1L1 U2AF2 NKTR SCAF4 SON CPSF7 | 7.27e-16 | 526 | 70 | 20 | int:CPSF6 |
| Interaction | CLK1 interactions | SRRM1 PPIG SRSF10 SRSF3 SRSF4 TRA2B LUC7L3 ZRSR2 CLK2 BCLAF1 DDX23 TRA2A U2AF2 SRSF11 SRSF12 | 9.14e-16 | 219 | 70 | 15 | int:CLK1 |
| Interaction | SRSF5 interactions | SRRM1 SCAF1 U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B TIAM1 AKAP17A ZRSR2 CDK13 RBMX2 CLK4 MEPCE TRA2A U2AF2 SREK1 SON | 1.68e-15 | 474 | 70 | 19 | int:SRSF5 |
| Interaction | SNRPA interactions | SRRM1 SETD2 PPIG SRSF10 SRSF4 TRA2B LUC7L3 CLK2 BCLAF1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 NKTR RSRC1 SCAF4 SON CPSF7 | 2.27e-15 | 482 | 70 | 19 | int:SNRPA |
| Interaction | RAD18 interactions | SCAF1 ZRSR2P1 PPIG SRSF4 TRA2B AKAP17A LUC7L3 CLK2 CPSF6 BCLAF1 RBMX2 DDX23 TRA2A FIP1L1 PRPF38B SCAF4 CPSF7 SRSF12 | 1.41e-14 | 457 | 70 | 18 | int:RAD18 |
| Interaction | SRRM2 interactions | SRRM1 U2AF1 SRSF3 SRSF4 TRA2B AKAP17A CLK2 CPSF6 LUC7L2 CLK4 TTC14 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 SRRM3 SON | 1.71e-14 | 462 | 70 | 18 | int:SRRM2 |
| Interaction | MYCN interactions | SRRM1 SCAF1 SETD2 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B CPSF6 CDK13 BCLAF1 LUC7L2 RBMX2 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B GPATCH8 CCDC9 RSRC1 SON CPSF7 SRSF12 | 2.58e-14 | 1373 | 70 | 27 | int:MYCN |
| Interaction | SNRPC interactions | SRRM1 SETD2 SRSF10 SRSF4 TRA2B LUC7L3 CPSF6 BCLAF1 DDX23 TRA2A FIP1L1 NKTR SREK1 GPATCH8 SCAF4 SON CPSF7 | 1.17e-13 | 440 | 70 | 17 | int:SNRPC |
| Interaction | NR2C2 interactions | SRRM1 SCAF1 PPIG SRSF10 FXR1 SRSF3 SRSF4 TRA2B AKAP17A LUC7L3 CLK2 CPSF6 LUC7L2 RBMX2 DHX38 PTDSS1 MEPCE DDX23 TRA2A U2AF2 SRSF11 PRPF38B NKTR SREK1 RSRC1 SON | 3.66e-13 | 1403 | 70 | 26 | int:NR2C2 |
| Interaction | SRSF10 interactions | SRSF10 SRSF3 SRSF4 TRA2B CLK2 CPSF6 LUC7L2 CLK4 DDX23 TRA2A U2AF2 SRSF11 SREK1 SRSF12 | 4.46e-13 | 271 | 70 | 14 | int:SRSF10 |
| Interaction | SRSF12 interactions | SRSF10 SRSF3 SRSF4 TIAM1 CLK2 LUC7L2 RBMX2 TRA2A U2AF2 SRSF11 SRSF12 | 8.20e-13 | 130 | 70 | 11 | int:SRSF12 |
| Interaction | SRSF8 interactions | 1.44e-12 | 98 | 70 | 10 | int:SRSF8 | |
| Interaction | SNRPB interactions | SRRM1 SETD2 PPIG SRSF4 TRA2B LUC7L3 ZRSR2 CPSF6 BCLAF1 MEPCE DDX23 U2AF2 NKTR RSRC1 SCAF4 SON CPSF7 | 1.56e-12 | 517 | 70 | 17 | int:SNRPB |
| Interaction | SRSF3 interactions | SRRM1 SCAF1 U2AF1 PPIG SRSF10 SRSF3 SRSF4 TRA2B CLK2 CDK13 MEPCE TRA2A U2AF2 SRSF11 SREK1 CCDC9 SRSF12 | 1.82e-12 | 522 | 70 | 17 | int:SRSF3 |
| Interaction | SNRPF interactions | SRRM1 PPIG TRA2B LUC7L3 ZRSR2 CPSF6 BCLAF1 MEPCE DDX23 TRA2A U2AF2 NKTR RSRC1 SCAF4 CPSF7 | 3.49e-12 | 385 | 70 | 15 | int:SNRPF |
| Interaction | BARD1 interactions | SRRM1 U2AF1 SRSF10 SRSF4 TRA2B LUC7L3 CPSF6 CDK13 BCLAF1 LUC7L2 MEPCE TRA2A U2AF2 SCAF4 | 4.80e-12 | 323 | 70 | 14 | int:BARD1 |
| Interaction | TRA2A interactions | SRRM1 PPIG SRSF10 SRSF3 SRSF4 TRA2B CLK2 CPSF6 LUC7L2 MEPCE TRA2A U2AF2 SRSF11 SRSF12 | 6.40e-12 | 330 | 70 | 14 | int:TRA2A |
| Interaction | TOP1 interactions | SRRM1 SCAF1 SETD2 TRA2B TIAM1 CPSF6 RBL2 BCLAF1 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SRSF11 TOPORS SCAF4 SON CPSF7 | 1.70e-11 | 696 | 70 | 18 | int:TOP1 |
| Interaction | THRAP3 interactions | PPIG FXR1 SRSF3 SRSF4 CLK2 CPSF6 BCLAF1 LUC7L2 PHRF1 MEPCE DDX23 TRA2A U2AF2 SRSF11 SREK1 | 2.55e-11 | 443 | 70 | 15 | int:THRAP3 |
| Interaction | NKAP interactions | U2AF1 PPIG AKAP17A CPSF6 LUC7L2 RBMX2 TTC14 DDX23 NKTR TOPORS | 2.93e-11 | 132 | 70 | 10 | int:NKAP |
| Interaction | ZCCHC10 interactions | SRRM1 U2AF1 PPIG AKAP17A CLK2 CPSF6 LUC7L2 SRSF11 NKTR SREK1 TOPORS SON | 2.94e-11 | 236 | 70 | 12 | int:ZCCHC10 |
| Interaction | NUP43 interactions | SRRM1 SCAF1 SETD2 SRSF10 SRSF3 PHF20L1 TRA2B LUC7L3 BCLAF1 LUC7L2 RBMX2 PHRF1 TTC14 NKTR SREK1 GPATCH8 SON | 3.13e-11 | 625 | 70 | 17 | int:NUP43 |
| Interaction | CSNK2A1 interactions | SRRM1 RIN3 SRSF10 FXR1 AKAP17A CLK2 CPSF6 RBL2 BCLAF1 LUC7L2 DHX38 CCNL1 PHRF1 MEPCE FIP1L1 SRSF11 NKTR SREK1 RSRC1 CPSF7 | 4.64e-11 | 956 | 70 | 20 | int:CSNK2A1 |
| Interaction | TRA2B interactions | SRRM1 U2AF1 SRSF10 SRSF3 SRSF4 TRA2B CLK2 CPSF6 LUC7L2 MEPCE TRA2A U2AF2 SRSF11 SREK1 | 4.99e-11 | 385 | 70 | 14 | int:TRA2B |
| Interaction | DHX40 interactions | SCAF1 SETD2 CLK2 CPSF6 BCLAF1 DHX38 TTC14 MEPCE DDX23 FIP1L1 GPATCH8 CPSF7 | 5.48e-11 | 249 | 70 | 12 | int:DHX40 |
| Interaction | RBM25 interactions | SRRM1 U2AF1 SRSF10 SRSF3 CPSF6 MEPCE DDX23 TRA2A FIP1L1 SRSF11 SREK1 RBM23 CPSF7 | 7.57e-11 | 323 | 70 | 13 | int:RBM25 |
| Interaction | YWHAG interactions | CEP350 SRRM1 PPIG SRSF10 FXR1 SRSF3 TRA2B TIAM1 AKAP17A LUC7L3 CLK2 BCLAF1 LUC7L2 MEPCE TRA2A FIP1L1 SRSF11 PRPF38B NKTR RSRC1 SON SRSF12 | 1.07e-10 | 1248 | 70 | 22 | int:YWHAG |
| Interaction | MAGOH interactions | SRRM1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B CPSF6 TRA2A CCDC9 SON CPSF7 SRSF12 | 1.08e-10 | 264 | 70 | 12 | int:MAGOH |
| Interaction | OBSL1 interactions | SRRM1 SCAF1 U2AF1 SRSF10 SRSF3 TRA2B LUC7L3 CPSF6 BCLAF1 ECM2 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B SCAF4 SON CPSF7 | 1.41e-10 | 902 | 70 | 19 | int:OBSL1 |
| Interaction | HERC2 interactions | SRRM1 U2AF1 PPIG FXR1 SRSF4 AKAP17A LUC7L3 CLK2 LUC7L2 CCNL1 PTDSS1 U2AF2 SRSF11 PRPF38B SREK1 | 1.51e-10 | 503 | 70 | 15 | int:HERC2 |
| Interaction | NCBP3 interactions | SRSF3 SRSF4 AKAP17A CLK2 CPSF6 LUC7L2 TRA2A SRSF11 CCDC9 RSRC1 | 1.54e-10 | 156 | 70 | 10 | int:NCBP3 |
| Interaction | IK interactions | U2AF1 SRSF10 FXR1 SRSF3 BCLAF1 LUC7L2 TTC14 DDX23 TRA2A U2AF2 SRSF11 | 1.97e-10 | 215 | 70 | 11 | int:IK |
| Interaction | PRPF38A interactions | 2.10e-10 | 161 | 70 | 10 | int:PRPF38A | |
| Interaction | ZRSR2 interactions | 2.44e-10 | 77 | 70 | 8 | int:ZRSR2 | |
| Interaction | UBR5 interactions | SRRM1 U2AF1 SRSF10 SRSF4 AKAP17A LUC7L3 LUC7L2 CCNL1 PTDSS1 DDX23 TRA2A U2AF2 PRPF38B SREK1 SON | 3.37e-10 | 533 | 70 | 15 | int:UBR5 |
| Interaction | CD2BP2 interactions | SRRM1 SRSF4 BCLAF1 DHX38 DDX23 SRSF11 PRPF38B NKTR GPATCH8 RSRC1 CPSF7 | 4.42e-10 | 232 | 70 | 11 | int:CD2BP2 |
| Interaction | ACIN1 interactions | SRRM1 U2AF1 SRSF4 CLK2 CPSF6 LUC7L2 PHRF1 DDX23 U2AF2 SRSF11 SCAF4 SON | 4.86e-10 | 301 | 70 | 12 | int:ACIN1 |
| Interaction | SUZ12 interactions | U2AF1 SRSF10 FXR1 SRSF3 TRA2B LUC7L3 CLK2 CPSF6 BCLAF1 LUC7L2 DDX23 TRA2A FIP1L1 U2AF2 SON CPSF7 | 4.91e-10 | 644 | 70 | 16 | int:SUZ12 |
| Interaction | U2AF1 interactions | U2AF1 SRSF3 TRA2B ZRSR2 CLK2 LUC7L2 DHX38 MEPCE DDX23 U2AF2 SON | 6.06e-10 | 239 | 70 | 11 | int:U2AF1 |
| Interaction | NKTR interactions | 8.67e-10 | 90 | 70 | 8 | int:NKTR | |
| Interaction | BRD3 interactions | SRRM1 SCAF1 TRA2B AKAP17A LUC7L2 DHX38 MEPCE TRA2A FIP1L1 U2AF2 SREK1 RSRC2 TOPORS SON | 1.30e-09 | 494 | 70 | 14 | int:BRD3 |
| Interaction | UFL1 interactions | SRRM1 SRSF10 FXR1 SRSF3 TRA2B AKAP17A LUC7L3 CPSF6 BCLAF1 LUC7L2 PTDSS1 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B CPSF7 | 1.32e-09 | 1031 | 70 | 19 | int:UFL1 |
| Interaction | PRP4K interactions | SRSF3 SRSF4 TRA2B CLK2 CPSF6 BCLAF1 LUC7L2 MEPCE DDX23 FIP1L1 SRSF11 CPSF7 | 1.34e-09 | 329 | 70 | 12 | int:PRP4K |
| Interaction | DOT1L interactions | SRRM1 U2AF1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B LUC7L3 LUC7L2 PTDSS1 MEPCE TRA2A FIP1L1 SRSF11 RSRC1 SON CPSF7 | 1.59e-09 | 807 | 70 | 17 | int:DOT1L |
| Interaction | ZRANB2 interactions | U2AF1 TRA2B AKAP17A LUC7L3 LUC7L2 DDX23 U2AF2 SRSF11 SREK1 SRRM3 | 1.67e-09 | 199 | 70 | 10 | int:ZRANB2 |
| Interaction | SRRM1 interactions | SRRM1 SRSF3 SRSF4 TRA2B CLK2 CPSF6 BCLAF1 DDX23 TRA2A U2AF2 SRSF11 RBM23 | 2.52e-09 | 348 | 70 | 12 | int:SRRM1 |
| Interaction | CSNK2B interactions | SRRM1 SETD2 RIN3 FXR1 AKAP17A CLK2 BCLAF1 LUC7L2 RBMX2 CCNL1 PHRF1 MEPCE NKTR TOPORS RSRC1 | 2.97e-09 | 625 | 70 | 15 | int:CSNK2B |
| Interaction | ZC3H11A interactions | PPIG SRSF10 SRSF3 AKAP17A CLK2 CPSF6 BCLAF1 TRA2A NKTR CCDC9 | 3.52e-09 | 215 | 70 | 10 | int:ZC3H11A |
| Interaction | RBBP6 interactions | 3.68e-09 | 216 | 70 | 10 | int:RBBP6 | |
| Interaction | HDLBP interactions | SRRM1 U2AF1 SRSF10 FXR1 AKAP17A LUC7L3 CPSF6 LUC7L2 RBMX2 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B SCAF4 CPSF7 | 3.79e-09 | 855 | 70 | 17 | int:HDLBP |
| Interaction | SNW1 interactions | SRRM1 U2AF1 FXR1 SRSF3 TRA2B LUC7L3 CPSF6 RBL2 LUC7L2 DHX38 TTC14 DDX23 FIP1L1 U2AF2 SRSF11 CPSF7 | 4.14e-09 | 747 | 70 | 16 | int:SNW1 |
| Interaction | ZBTB2 interactions | SCAF1 PPIG SRSF10 FXR1 SRSF4 TRA2B LUC7L3 BCLAF1 RBMX2 TRA2A NKTR SON SRSF12 | 4.31e-09 | 450 | 70 | 13 | int:ZBTB2 |
| Interaction | DDRGK1 interactions | SRRM1 RIN3 SRSF10 FXR1 SRSF3 TRA2B AKAP17A LUC7L3 CPSF6 BCLAF1 LUC7L2 RBMX2 PTDSS1 DDX23 TRA2A FIP1L1 U2AF2 SRSF11 PRPF38B CPSF7 | 4.95e-09 | 1249 | 70 | 20 | int:DDRGK1 |
| Interaction | SRSF9 interactions | SRSF10 FXR1 SRSF3 TRA2B CPSF6 BCLAF1 TRA2A U2AF2 SRSF11 SREK1 | 5.22e-09 | 224 | 70 | 10 | int:SRSF9 |
| Interaction | RBMX interactions | SRRM1 SRSF10 SRSF3 SRSF4 TRA2B CPSF6 DHX38 MEPCE DDX23 TRA2A U2AF2 SREK1 CPSF7 | 5.75e-09 | 461 | 70 | 13 | int:RBMX |
| Interaction | FOLR1 interactions | U2AF1 SRSF3 LUC7L3 CPSF6 LUC7L2 U2AF2 SRSF11 PRPF38B SREK1 RSRC1 | 5.93e-09 | 227 | 70 | 10 | int:FOLR1 |
| Interaction | MEN1 interactions | SRRM1 SRSF10 FXR1 SRSF3 SRSF4 PHF20L1 LUC7L3 CPSF6 BCLAF1 DHX38 PTDSS1 MEPCE DDX23 TRA2A FIP1L1 U2AF2 SREK1 SON | 8.94e-09 | 1029 | 70 | 18 | int:MEN1 |
| Interaction | KIF23 interactions | SRRM1 U2AF1 PPIG SRSF10 FXR1 SRSF3 TRA2B AKAP17A LUC7L3 BCLAF1 DHX38 MEPCE DDX23 TRA2A U2AF2 PRPF38B SON SRSF12 | 9.22e-09 | 1031 | 70 | 18 | int:KIF23 |
| Interaction | CIT interactions | SRRM1 SCAF1 SRSF10 FXR1 SRSF3 TRA2B LUC7L3 BCLAF1 DHX38 MEPCE DDX23 TRA2A FIP1L1 U2AF2 PRPF38B NKTR SREK1 RBM23 SON CPSF7 SRSF12 | 1.09e-08 | 1450 | 70 | 21 | int:CIT |
| Interaction | SART1 interactions | U2AF1 SRSF4 LUC7L3 ZRSR2 CPSF6 MEPCE DDX23 FIP1L1 U2AF2 SRSF11 CPSF7 | 1.16e-08 | 317 | 70 | 11 | int:SART1 |
| Interaction | RNF113A interactions | SRRM1 U2AF1 PPIG FXR1 SRSF3 TRA2B LUC7L3 CDK13 BCLAF1 LUC7L2 MEPCE DDX23 U2AF2 SRSF11 SREK1 | 1.17e-08 | 692 | 70 | 15 | int:RNF113A |
| Interaction | PRPF6 interactions | U2AF1 ZRSR2 CLK2 CPSF6 LUC7L2 MEPCE DDX23 TRA2A U2AF2 SON CPSF7 | 2.12e-08 | 336 | 70 | 11 | int:PRPF6 |
| Interaction | SF3B2 interactions | SRRM1 U2AF1 RIN3 FXR1 SRSF3 SRSF4 TRA2B ZRSR2 CPSF6 TTC14 MEPCE U2AF2 SRSF11 | 2.24e-08 | 517 | 70 | 13 | int:SF3B2 |
| Interaction | S100A9 interactions | U2AF1 SRSF10 SRSF3 TRA2B LUC7L3 TRA2A U2AF2 SRSF11 TOPORS SON | 2.59e-08 | 265 | 70 | 10 | int:S100A9 |
| Interaction | SMC5 interactions | SRRM1 U2AF1 SETD2 SRSF10 SRSF3 SRSF4 LUC7L3 CPSF6 BCLAF1 FIP1L1 U2AF2 SRSF11 SREK1 SCAF4 SON CPSF7 SRSF12 | 3.83e-08 | 1000 | 70 | 17 | int:SMC5 |
| Interaction | BMI1 interactions | SRRM1 U2AF1 FXR1 SRSF3 SRSF4 LUC7L3 BCLAF1 MEPCE DDX23 TRA2A GPATCH8 RSRC1 SON CPSF7 | 4.96e-08 | 659 | 70 | 14 | int:BMI1 |
| Interaction | RC3H2 interactions | SRRM1 SRSF10 FXR1 SRSF3 SRSF4 TRA2B CPSF6 CDK13 BCLAF1 LUC7L2 U2AF2 SRSF11 SREK1 SON | 5.76e-08 | 667 | 70 | 14 | int:RC3H2 |
| Interaction | PIP4K2A interactions | 5.83e-08 | 216 | 70 | 9 | int:PIP4K2A | |
| Interaction | SRSF2 interactions | SRRM1 U2AF1 SRSF3 SRSF4 TRA2B ZRSR2 CCNL1 U2AF2 SRSF11 SREK1 | 6.04e-08 | 290 | 70 | 10 | int:SRSF2 |
| Interaction | SFPQ interactions | SRRM1 U2AF1 FXR1 SRSF3 SRSF4 CPSF6 MEPCE DDX23 U2AF2 SREK1 TOPORS SON CPSF7 | 6.07e-08 | 563 | 70 | 13 | int:SFPQ |
| Interaction | ATXN1 interactions | SRRM1 U2AF1 SETD2 PPIG SRSF10 FXR1 SRSF3 TRA2B CPSF6 CDK13 BCLAF1 LUC7L2 U2AF2 GPATCH8 WNK2 RSRC1 CPSF7 | 6.67e-08 | 1039 | 70 | 17 | int:ATXN1 |
| Interaction | MFAP1 interactions | 7.09e-08 | 295 | 70 | 10 | int:MFAP1 | |
| Cytoband | 9q22.3 | 1.50e-04 | 12 | 70 | 2 | 9q22.3 | |
| Cytoband | 7p15.3 | 9.06e-04 | 29 | 70 | 2 | 7p15.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 1.03e-03 | 290 | 70 | 4 | chr1q32 | |
| Cytoband | 11q12.2 | 1.64e-03 | 39 | 70 | 2 | 11q12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 2.68e-03 | 377 | 70 | 4 | chr21q22 | |
| Cytoband | 21q22.11 | 4.08e-03 | 62 | 70 | 2 | 21q22.11 | |
| Cytoband | 1p36.11 | 4.89e-03 | 68 | 70 | 2 | 1p36.11 | |
| GeneFamily | RNA binding motif containing | U2AF1 ZRSR2P1 SRSF10 SRSF3 SRSF4 TRA2B ZRSR2 CPSF6 RBMX2 TRA2A U2AF2 SRSF11 SREK1 RBM23 SCAF4 CPSF7 SRSF12 | 1.10e-21 | 213 | 46 | 17 | 725 |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 6.66e-11 | 12 | 46 | 5 | 737 | |
| GeneFamily | CDC like kinases | 3.79e-05 | 4 | 46 | 2 | 480 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 1.05e-03 | 19 | 46 | 2 | 909 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 1.42e-03 | 22 | 46 | 2 | 579 | |
| GeneFamily | Zinc fingers CCCH-type | 3.57e-03 | 35 | 46 | 2 | 73 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.09e-02 | 181 | 46 | 3 | 694 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 1.35e-10 | 199 | 70 | 10 | M6060 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | U2AF1 SRSF10 AKAP17A BCLAF1 LUC7L2 CLK4 CCNL1 TRA2A NKTR SREK1 RSRC2 SON | 1.55e-09 | 432 | 70 | 12 | M41149 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CEP350 PPIG FXR1 PHF20L1 LUC7L3 BCLAF1 CCNL1 NOX4 SRSF11 PRPF38B NKTR SREK1 RSRC2 SON | 1.75e-09 | 656 | 70 | 14 | M18979 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SRRM1 SCAF1 U2AF1 SRSF10 SRSF3 SRSF4 LUC7L3 ZRSR2 RBMX2 DHX38 PHRF1 MEPCE DDX23 U2AF2 SRSF11 RSRC2 SON | 4.88e-09 | 1129 | 70 | 17 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SRRM1 SCAF1 U2AF1 SRSF10 SRSF3 SRSF4 LUC7L3 ZRSR2 RBMX2 DHX38 PHRF1 MEPCE DDX23 U2AF2 SRSF11 RSRC2 SON | 7.11e-09 | 1158 | 70 | 17 | MM1338 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 1.48e-08 | 166 | 70 | 8 | M8129 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | SETD2 PPIG SRSF3 PHF20L1 BCLAF1 LUC7L2 CLK4 SRSF11 NKTR RSRC2 | 4.35e-08 | 363 | 70 | 10 | M41103 |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 1.01e-06 | 198 | 70 | 7 | M7605 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | U2AF1 SRSF10 FXR1 SRSF3 TRA2B LUC7L3 CPSF6 CCNL1 TRA2A PRPF38B RSRC2 | 1.05e-06 | 644 | 70 | 11 | M41717 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CEP350 SETD2 PPIG SRSF10 PHF20L1 TRA2B CDK13 RBL2 BCLAF1 CCNL1 PTDSS1 TTC14 PRPF38B GPATCH8 RSRC2 SON | 1.49e-06 | 1492 | 70 | 16 | M40023 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | PPIG SRSF10 SRSF3 TRA2B LUC7L3 CPSF6 BCLAF1 CLK4 TTC14 SRSF11 SREK1 | 1.97e-06 | 687 | 70 | 11 | M41022 |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 2.23e-06 | 223 | 70 | 7 | M17621 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP | 6.34e-06 | 170 | 70 | 6 | M6697 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | SRRM1 U2AF1 PPIG SRSF3 TRA2B LUC7L3 LUC7L2 CCNL1 U2AF2 SRSF11 PRPF38B RSRC2 SON | 9.12e-06 | 1144 | 70 | 13 | MM3843 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 1.22e-05 | 404 | 70 | 8 | M19488 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 1.22e-05 | 534 | 70 | 9 | MM1054 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 1.55e-05 | 199 | 70 | 6 | M7596 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 1.55e-05 | 199 | 70 | 6 | M7607 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | ZNF8 SRRM1 U2AF1 PPIG SRSF10 SRSF3 TRA2B TIAM1 AKAP17A CLK2 CDK13 TRA2A SRSF11 NKTR | 1.59e-05 | 1394 | 70 | 14 | M9585 |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 1.60e-05 | 200 | 70 | 6 | M9472 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | 1.60e-05 | 200 | 70 | 6 | M4313 | |
| Coexpression | GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP | 1.90e-05 | 59 | 70 | 4 | M17730 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 2.26e-05 | 318 | 70 | 7 | M41707 | |
| Coexpression | BENPORATH_SOX2_TARGETS | SCAF1 SRSF4 BCLAF1 DHX38 TRA2A FIP1L1 NKTR RSRC2 RBM23 SCAF4 | 2.43e-05 | 734 | 70 | 10 | M3835 |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | 2.81e-05 | 454 | 70 | 8 | M19927 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN | 3.34e-05 | 137 | 70 | 5 | M4781 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | 3.56e-05 | 612 | 70 | 9 | MM3804 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 3.81e-05 | 474 | 70 | 8 | M40991 | |
| Coexpression | BENPORATH_NANOG_TARGETS | SCAF1 FXR1 SRSF4 TIAM1 BCLAF1 DHX38 DDX23 NKTR RSRC2 SCAF4 SON | 5.83e-05 | 988 | 70 | 11 | M6616 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SETD2 FXR1 AKAP17A CLK4 CCNL1 SRSF11 SREK1 GPATCH8 RSRC2 TOPORS | 6.30e-05 | 822 | 70 | 10 | M6782 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 7.20e-05 | 519 | 70 | 8 | M3395 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 7.60e-05 | 523 | 70 | 8 | M12707 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 8.33e-05 | 166 | 70 | 5 | M6826 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 9.85e-05 | 543 | 70 | 8 | MM997 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 1.34e-04 | 568 | 70 | 8 | M4023 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | 1.47e-04 | 911 | 70 | 10 | M40038 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 1.48e-04 | 429 | 70 | 7 | M29 | |
| Coexpression | PGF_UP.V1_UP | 1.57e-04 | 190 | 70 | 5 | M2674 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 1.81e-04 | 196 | 70 | 5 | M4928 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 1.86e-04 | 197 | 70 | 5 | M3193 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 1.90e-04 | 198 | 70 | 5 | M7610 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN | 1.90e-04 | 198 | 70 | 5 | M3401 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_DN | 1.90e-04 | 198 | 70 | 5 | M9530 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP | 1.90e-04 | 198 | 70 | 5 | M3129 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 1.95e-04 | 199 | 70 | 5 | M9501 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP | 1.95e-04 | 199 | 70 | 5 | M4521 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 1.95e-04 | 199 | 70 | 5 | M6638 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN | 1.95e-04 | 199 | 70 | 5 | M3716 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 1.99e-04 | 200 | 70 | 5 | M4817 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | SRRM1 U2AF1 CLK2 LUC7L2 TTC14 NKTR GRIK5 GPATCH8 SRRM3 CCDC9 | 2.13e-04 | 954 | 70 | 10 | MM3689 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 2.13e-04 | 203 | 70 | 5 | MM3795 | |
| Coexpression | KIM_WT1_TARGETS_DN | 2.61e-04 | 471 | 70 | 7 | M17859 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_DN | 3.17e-04 | 344 | 70 | 6 | M2239 | |
| Coexpression | BENPORATH_CYCLING_GENES | 3.27e-04 | 648 | 70 | 8 | M8156 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | 5.27e-04 | 877 | 70 | 9 | M2241 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | 5.28e-04 | 379 | 70 | 6 | M1885 | |
| Coexpression | FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL | 5.64e-04 | 251 | 70 | 5 | M41709 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 5.89e-04 | 143 | 70 | 4 | M9149 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | CEP350 PPIG RIN3 SRSF10 LUC7L3 MEPCE TRA2A SRSF11 SREK1 RSRC2 | 6.01e-04 | 1088 | 70 | 10 | MM3699 |
| Coexpression | GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN | 6.87e-04 | 149 | 70 | 4 | M6708 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | 7.77e-04 | 154 | 70 | 4 | M6824 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 8.10e-04 | 272 | 70 | 5 | M15123 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN | 8.24e-04 | 16 | 70 | 2 | M17006 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 8.69e-04 | 417 | 70 | 6 | M39224 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SRRM1 SP4 SRSF3 TRA2B LUC7L3 BCLAF1 LUC7L2 TTC14 FIP1L1 NOX4 SRSF11 PRPF38B NKTR RSRC2 TOPORS | 3.32e-08 | 801 | 69 | 15 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SRRM1 SP4 SRSF3 PHF20L1 TRA2B LUC7L3 BCLAF1 LUC7L2 TTC14 FIP1L1 SRSF11 PRPF38B NKTR RSRC2 TOPORS | 3.60e-08 | 806 | 69 | 15 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CEP350 SRRM1 SP4 PPIG TRA2B LUC7L3 CLK2 CPSF6 BCLAF1 RBMX2 TTC14 FIP1L1 SRSF11 PRPF38B SREK1 RSRC2 TOPORS RSRC1 | 6.78e-08 | 1257 | 69 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.11e-07 | 249 | 69 | 9 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.56e-07 | 259 | 69 | 9 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.58e-07 | 275 | 69 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.10e-07 | 281 | 69 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.39e-07 | 284 | 69 | 9 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CEP350 SRRM1 SP4 PPIG TRA2B LUC7L3 CLK2 CPSF6 BCLAF1 RBMX2 TTC14 FIP1L1 SRSF11 PRPF38B SREK1 RSRC2 TOPORS RSRC1 | 6.22e-07 | 1459 | 69 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | FXR1 PHF20L1 ZRSR2 BCLAF1 C16orf87 DHX38 CCNL1 TTC14 TRA2A RSRC2 TOPORS | 1.08e-06 | 532 | 69 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SRRM1 SRSF3 TRA2B LUC7L3 BCLAF1 LUC7L2 TTC14 FIP1L1 NOX4 SRSF11 NKTR RSRC2 TOPORS | 1.34e-06 | 790 | 69 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SRRM1 SRSF3 TRA2B LUC7L3 BCLAF1 LUC7L2 TTC14 FIP1L1 NOX4 SRSF11 NKTR RSRC2 TOPORS | 1.51e-06 | 799 | 69 | 13 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SRRM1 SP4 PPIG SRSF10 SRSF4 TRA2B LUC7L3 CLK4 PRPF38B GPATCH8 SON | 3.19e-06 | 595 | 69 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SRRM1 SP4 SRSF3 TRA2B LUC7L3 BCLAF1 LUC7L2 TTC14 NOX4 SRSF11 PRPF38B NKTR | 8.87e-06 | 797 | 69 | 12 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.45e-05 | 162 | 69 | 6 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.22e-05 | 277 | 69 | 7 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SRRM1 PPIG SRSF10 TRA2B LUC7L3 PLCH2 CLK4 SRSF11 PRPF38B SON | 3.41e-05 | 629 | 69 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 5.03e-05 | 406 | 69 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 5.68e-05 | 413 | 69 | 8 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.37e-04 | 469 | 69 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SRRM1 SRSF3 TRA2B LUC7L3 BCLAF1 LUC7L2 TTC14 FIP1L1 SRSF11 TOPORS | 2.58e-04 | 804 | 69 | 10 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 3.30e-04 | 403 | 69 | 7 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.49e-04 | 186 | 69 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SRRM1 SP4 PPIG LUC7L3 CLK2 CPSF6 BCLAF1 RBMX2 MEPCE FIP1L1 PRPF38B GPATCH8 WNK2 | 4.12e-04 | 1370 | 69 | 13 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.75e-04 | 564 | 69 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.07e-04 | 210 | 69 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.34e-04 | 323 | 69 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 8.84e-04 | 776 | 69 | 9 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.13e-04 | 230 | 69 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 1.01e-03 | 136 | 69 | 4 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 1.07e-03 | 492 | 69 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.25e-03 | 815 | 69 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#1 | RIN3 CLK4 CCNL1 PHRF1 FIP1L1 PRPF38B RSRC2 RBM23 SCAF4 CPSF7 | 1.32e-03 | 993 | 69 | 10 | ratio_EB-blastocyst_vs_EB-fibro_2500_K1 |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | SRRM1 PPIG SRSF10 SRSF3 TRA2B LUC7L3 CLK4 C16orf87 TRA2A FIP1L1 SREK1 RSRC2 | 3.21e-16 | 198 | 70 | 12 | abfddbee99ef8c7719e6e6f62571e9be030e4acf |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | CEP350 SETD2 SRSF10 TRA2B CDK13 BCLAF1 CCNL1 SRSF11 NKTR SREK1 RSRC2 SON | 3.62e-16 | 200 | 70 | 12 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | SRRM1 PPIG SRSF10 SRSF3 TRA2B LUC7L3 CLK4 TRA2A FIP1L1 SREK1 RSRC2 | 1.40e-14 | 196 | 70 | 11 | ad43efdd4d73b6615f65f06a315b33576e317473 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | CEP350 PPIG LUC7L3 ZRSR2 CCNL1 SRSF11 PRPF38B NKTR SREK1 RSRC2 | 6.50e-13 | 197 | 70 | 10 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-11 | 188 | 70 | 9 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 2.22e-11 | 194 | 70 | 9 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 2.66e-11 | 198 | 70 | 9 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.91e-11 | 200 | 70 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 5.56e-10 | 186 | 70 | 8 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.77e-10 | 197 | 70 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.49e-10 | 199 | 70 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.13e-08 | 191 | 70 | 7 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.21e-08 | 192 | 70 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.63e-08 | 197 | 70 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.73e-08 | 198 | 70 | 7 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.73e-08 | 198 | 70 | 7 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.73e-08 | 198 | 70 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-08 | 198 | 70 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-07 | 187 | 70 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.02e-07 | 193 | 70 | 6 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 6.02e-07 | 193 | 70 | 6 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 6.98e-07 | 198 | 70 | 6 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.98e-07 | 198 | 70 | 6 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.19e-07 | 199 | 70 | 6 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.41e-07 | 200 | 70 | 6 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.55e-06 | 147 | 70 | 5 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 184 | 70 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.09e-05 | 185 | 70 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.14e-05 | 187 | 70 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.17e-05 | 188 | 70 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.20e-05 | 189 | 70 | 5 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.33e-05 | 193 | 70 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 1.36e-05 | 194 | 70 | 5 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 1.47e-05 | 197 | 70 | 5 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.47e-05 | 197 | 70 | 5 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-05 | 197 | 70 | 5 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 198 | 70 | 5 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.51e-05 | 198 | 70 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.51e-05 | 198 | 70 | 5 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.54e-05 | 199 | 70 | 5 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.54e-05 | 199 | 70 | 5 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 166 | 70 | 4 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 169 | 70 | 4 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | 3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue | 1.52e-04 | 171 | 70 | 4 | 7aae88da5b37c20f10118325a048f08906be994c | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 174 | 70 | 4 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 178 | 70 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.01e-04 | 184 | 70 | 4 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.01e-04 | 184 | 70 | 4 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 186 | 70 | 4 | 064b6047215597465bb51a8a1547ef5a226552f9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.23e-04 | 189 | 70 | 4 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.27e-04 | 190 | 70 | 4 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.36e-04 | 192 | 70 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.36e-04 | 192 | 70 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 193 | 70 | 4 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.41e-04 | 193 | 70 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 193 | 70 | 4 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | remission|World / disease stage, cell group and cell class | 2.41e-04 | 193 | 70 | 4 | 86cfd0c230ba96a43d343216935952fff6a5254e | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 194 | 70 | 4 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 194 | 70 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 194 | 70 | 4 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.51e-04 | 195 | 70 | 4 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 195 | 70 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|World / Lineage, cell class and subclass | 2.56e-04 | 196 | 70 | 4 | 78b006922307c154622d71fcbc79ae5eed3f4b23 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.56e-04 | 196 | 70 | 4 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-04 | 196 | 70 | 4 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 2.61e-04 | 197 | 70 | 4 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.61e-04 | 197 | 70 | 4 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | PBMC|World / Compartment, Disease Groups and Clusters | 2.66e-04 | 198 | 70 | 4 | 84f5b43dad0c57556171dbc0b799735654582ecf | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-04 | 199 | 70 | 4 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 2.71e-04 | 199 | 70 | 4 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.71e-04 | 199 | 70 | 4 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.71e-04 | 199 | 70 | 4 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.71e-04 | 199 | 70 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.71e-04 | 199 | 70 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.76e-04 | 200 | 70 | 4 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-04 | 200 | 70 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.76e-04 | 200 | 70 | 4 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.76e-04 | 200 | 70 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| Computational | RNA splicing. | 7.95e-07 | 65 | 54 | 6 | MODULE_183 | |
| Computational | Neighborhood of HDAC1 | 1.16e-06 | 110 | 54 | 7 | GNF2_HDAC1 | |
| Computational | Neighborhood of G22P1 | 2.97e-05 | 36 | 54 | 4 | GNF2_G22P1 | |
| Computational | Neighborhood of APEX1 | 9.35e-05 | 92 | 54 | 5 | GNF2_APEX1 | |
| Computational | Neighborhood of APEX1 | 2.57e-04 | 114 | 54 | 5 | GCM_APEX1 | |
| Computational | Neighborhood of ACTG1 | 3.79e-04 | 124 | 54 | 5 | GCM_ACTG1 | |
| Computational | Neighborhood of ACP1 | 6.27e-04 | 211 | 54 | 6 | MORF_ACP1 | |
| Computational | Neighborhood of TDG | 7.00e-04 | 35 | 54 | 3 | GNF2_TDG | |
| Computational | Genes in the cancer module 98. | 7.08e-04 | 393 | 54 | 8 | MODULE_98 | |
| Computational | Neighborhood of FBL | 7.99e-04 | 146 | 54 | 5 | GNF2_FBL | |
| Computational | Neighborhood of RAD21 | 8.25e-04 | 37 | 54 | 3 | GCM_RAD21 | |
| Computational | Neighborhood of UBE2N | 1.29e-03 | 95 | 54 | 4 | MORF_UBE2N | |
| Computational | Neighborhood of UBE2I | 1.37e-03 | 44 | 54 | 3 | GNF2_UBE2I | |
| Computational | Neighborhood of MLL | 1.75e-03 | 174 | 54 | 5 | GCM_MLL | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.88e-03 | 49 | 54 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.99e-03 | 50 | 54 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Neighborhood of DEK | 1.99e-03 | 264 | 54 | 6 | MORF_DEK | |
| Computational | Neighborhood of DAP3 | 2.95e-03 | 119 | 54 | 4 | GNF2_DAP3 | |
| Computational | Neighborhood of DEK | 3.04e-03 | 58 | 54 | 3 | GNF2_DEK | |
| Drug | AC1NRA5C | U2AF1 SRSF10 SRSF3 SRSF4 TRA2B AKAP17A CDK13 CCNL1 TRA2A U2AF2 SREK1 RBM23 SRSF12 | 6.27e-15 | 174 | 70 | 13 | CID005287709 |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.71e-08 | 172 | 70 | 8 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.71e-08 | 172 | 70 | 8 | 6993_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.12e-06 | 175 | 70 | 7 | 1058_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.30e-06 | 179 | 70 | 7 | 4585_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.75e-06 | 187 | 70 | 7 | 4302_DN | |
| Drug | ((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one) | 6.00e-06 | 12 | 70 | 3 | ctd:C578491 | |
| Drug | testosterone enanthate | 9.92e-06 | 575 | 70 | 10 | ctd:C004648 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.14e-05 | 164 | 70 | 6 | 3852_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.18e-05 | 165 | 70 | 6 | 5625_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.40e-05 | 170 | 70 | 6 | 1050_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.60e-05 | 174 | 70 | 6 | 5580_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.65e-05 | 175 | 70 | 6 | 5935_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.65e-05 | 175 | 70 | 6 | 1014_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.76e-05 | 177 | 70 | 6 | 5308_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.82e-05 | 178 | 70 | 6 | 5086_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.82e-05 | 178 | 70 | 6 | 3998_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.82e-05 | 178 | 70 | 6 | 6276_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.06e-05 | 182 | 70 | 6 | 1891_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.13e-05 | 183 | 70 | 6 | 4770_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 2.63e-05 | 190 | 70 | 6 | 1612_DN | |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HG-U133A | 3.22e-05 | 197 | 70 | 6 | 1931_DN | |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; HL60; HG-U133A | 3.40e-05 | 199 | 70 | 6 | 2001_UP | |
| Drug | 2-(ethylsulfonyl)ethanol | 4.60e-05 | 210 | 70 | 6 | CID000010549 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 1.31e-04 | 159 | 70 | 5 | 4328_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.39e-04 | 161 | 70 | 5 | 4768_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.47e-04 | 163 | 70 | 5 | 5594_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.56e-04 | 165 | 70 | 5 | 6085_DN | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.56e-04 | 165 | 70 | 5 | 3851_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.56e-04 | 165 | 70 | 5 | 2835_DN | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.60e-04 | 166 | 70 | 5 | 5324_UP | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.65e-04 | 167 | 70 | 5 | 5217_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.69e-04 | 168 | 70 | 5 | 3868_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.69e-04 | 168 | 70 | 5 | 6820_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.74e-04 | 169 | 70 | 5 | 6064_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.79e-04 | 170 | 70 | 5 | 7043_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.84e-04 | 171 | 70 | 5 | 7407_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.84e-04 | 171 | 70 | 5 | 1000_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.84e-04 | 171 | 70 | 5 | 6879_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.84e-04 | 171 | 70 | 5 | 4954_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.89e-04 | 172 | 70 | 5 | 4112_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.89e-04 | 172 | 70 | 5 | 6439_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.89e-04 | 172 | 70 | 5 | 2330_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.89e-04 | 172 | 70 | 5 | 5209_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.89e-04 | 172 | 70 | 5 | 1637_DN | |
| Drug | metrizoate | 1.94e-04 | 7 | 70 | 2 | CID000002528 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.94e-04 | 173 | 70 | 5 | 4565_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.94e-04 | 173 | 70 | 5 | 5336_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.99e-04 | 174 | 70 | 5 | 6579_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.99e-04 | 174 | 70 | 5 | 909_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.99e-04 | 174 | 70 | 5 | 5945_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.99e-04 | 174 | 70 | 5 | 5693_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.05e-04 | 175 | 70 | 5 | 3787_DN | |
| Drug | SAHA; Down 200; 10uM; PC3; HT_HG-U133A | 2.05e-04 | 175 | 70 | 5 | 1220_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.05e-04 | 175 | 70 | 5 | 7236_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.10e-04 | 176 | 70 | 5 | 3312_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.10e-04 | 176 | 70 | 5 | 1212_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.10e-04 | 176 | 70 | 5 | 6784_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.10e-04 | 176 | 70 | 5 | 981_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.10e-04 | 176 | 70 | 5 | 6932_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.10e-04 | 176 | 70 | 5 | 1535_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.16e-04 | 177 | 70 | 5 | 873_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.16e-04 | 177 | 70 | 5 | 6972_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.16e-04 | 177 | 70 | 5 | 985_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.16e-04 | 177 | 70 | 5 | 3227_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.22e-04 | 178 | 70 | 5 | 1471_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.22e-04 | 178 | 70 | 5 | 7245_DN | |
| Drug | fisetin; Down 200; 50uM; PC3; HG-U133A | 2.22e-04 | 178 | 70 | 5 | 579_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.22e-04 | 178 | 70 | 5 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.22e-04 | 178 | 70 | 5 | 4710_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.22e-04 | 178 | 70 | 5 | 1112_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.33e-04 | 180 | 70 | 5 | 6886_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.39e-04 | 181 | 70 | 5 | 7077_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.39e-04 | 181 | 70 | 5 | 6951_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.46e-04 | 182 | 70 | 5 | 1951_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.58e-04 | 184 | 70 | 5 | 6939_DN | |
| Drug | 2-deoxy-D-glucose; Up 200; 10000uM; MCF7; HG-U133A | 2.71e-04 | 186 | 70 | 5 | 344_UP | |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 2.78e-04 | 187 | 70 | 5 | 3075_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A | 2.85e-04 | 188 | 70 | 5 | 345_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.85e-04 | 188 | 70 | 5 | 6735_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.92e-04 | 189 | 70 | 5 | 4271_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.99e-04 | 190 | 70 | 5 | 4322_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 3.07e-04 | 191 | 70 | 5 | 4269_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 3.14e-04 | 192 | 70 | 5 | 458_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 3858_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 3.14e-04 | 192 | 70 | 5 | 1971_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 3906_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 4361_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 4312_DN | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 7523_UP | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; HL60; HG-U133A | 3.45e-04 | 196 | 70 | 5 | 2036_DN | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 2780_DN | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 4469_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; HL60; HG-U133A | 3.54e-04 | 197 | 70 | 5 | 1551_DN | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; HL60; HG-U133A | 3.54e-04 | 197 | 70 | 5 | 1717_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 4266_DN | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; HL60; HG-U133A | 3.62e-04 | 198 | 70 | 5 | 1619_DN | |
| Drug | 5255229; Down 200; 13uM; MCF7; HT_HG-U133A_EA | 3.62e-04 | 198 | 70 | 5 | 833_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; HL60; HG-U133A | 3.62e-04 | 198 | 70 | 5 | 2002_UP | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HG-U133A | 3.70e-04 | 199 | 70 | 5 | 1936_UP | |
| Disease | right ventricular diastolic volume measurement | 3.07e-05 | 28 | 64 | 3 | EFO_0021814 | |
| Disease | Chronic Lymphocytic Leukemia | 2.36e-04 | 55 | 64 | 3 | C0023434 | |
| Disease | palmitoylcarnitine measurement | 9.47e-04 | 21 | 64 | 2 | EFO_0021044 | |
| Disease | bone density, lean body mass | 9.47e-04 | 21 | 64 | 2 | EFO_0003923, EFO_0004995 | |
| Disease | macular degeneration (is_marker_for) | 1.46e-03 | 26 | 64 | 2 | DOID:4448 (is_marker_for) | |
| Disease | Retinitis Pigmentosa | 1.52e-03 | 104 | 64 | 3 | C0035334 | |
| Disease | Hematopoetic Myelodysplasia | 1.81e-03 | 29 | 64 | 2 | C2713368 | |
| Disease | cardiovascular disease | 3.14e-03 | 457 | 64 | 5 | EFO_0000319 | |
| Disease | systemic juvenile idiopathic arthritis | 3.43e-03 | 40 | 64 | 2 | EFO_1001999 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 3.95e-03 | 43 | 64 | 2 | DOID:12930 (is_implicated_in) | |
| Disease | response to tenofovir | 5.51e-03 | 51 | 64 | 2 | EFO_0009279 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HRSFERSHRRISERS | 1831 | Q68DN1 | |
| SSYRSQRSSRRKHRR | 106 | P49760 | |
| RRRRSRTFSRSSSQH | 121 | P49760 | |
| RDRRERSRSFERSHK | 496 | Q9UK58 | |
| RARKSRNRLSSSSQH | 466 | O00305 | |
| DRRSSSGRSKERHRE | 201 | Q14004 | |
| SHNKSRDRKRSRSRD | 66 | Q86U06 | |
| SRSRSRDKSHRHKRA | 291 | Q9Y388 | |
| RHKRARRSRERESSN | 301 | Q9Y388 | |
| SSRKRHRSRERSPSR | 416 | Q8N684 | |
| RKRRNSGSSDSRSHQ | 936 | Q08999 | |
| RRRHRNLSSTTDDEA | 31 | O00515 | |
| RHRKRRRTSSKSEAG | 361 | Q7L2J0 | |
| PHSNRRFSSRRRDDS | 496 | Q9NQ76 | |
| TDASESHHSTNRRRR | 491 | P51114 | |
| SSHRRRTGESRHKTR | 436 | Q8IYT1 | |
| RKHRDFRSSDFSRSS | 2611 | Q2LD37 | |
| QRRAGTKRSSRSSHR | 796 | Q9UKJ3 | |
| QSRSRSRSHTRERSR | 941 | Q9UKJ3 | |
| SRSRSKRRSRSTTAH | 966 | Q9UKJ3 | |
| SDSLQRRHTSRKLRD | 451 | Q8NA70 | |
| HKSSRSNSRRRHESE | 541 | Q6UN15 | |
| RDRRKRRSRSPSSEH | 1156 | Q9P1Y6 | |
| KRSRSRSRHSSRTSD | 291 | O95232 | |
| RSRHSSRTSDRRCSR | 296 | O95232 | |
| SRTSDRRCSRSRDHK | 301 | O95232 | |
| RRSRSHDRSERKHRS | 331 | O95232 | |
| RKHRSRSRDRRRSKS | 341 | O95232 | |
| SRSRSKSAERERRHK | 61 | Q9BUQ8 | |
| SRRTRRLLDKSRTFH | 91 | Q9NPH5 | |
| RSRTHDRDRSRSKEY | 576 | Q13427 | |
| RSRRSRRSRSDNALH | 686 | Q7Z3G6 | |
| RSSVTNRARASKDRR | 286 | Q8WWV6 | |
| RSREKSRRHKSRSRD | 501 | Q16630 | |
| RSRSNSHSDHIRRGR | 86 | Q6PH81 | |
| QHKAEASSRRRRKSS | 336 | Q9Y3X0 | |
| KRRSVSSQRSRSRSR | 116 | Q9NYF8 | |
| HRHLQRNSERSRSKS | 481 | Q5VT06 | |
| RRLRKSSTSHKHRSN | 36 | O94769 | |
| SRSKSHRRKRSRSIE | 126 | Q9HAZ1 | |
| HAVSCRKTSRSRRRR | 851 | Q16478 | |
| RHMSDNRKSRSRSAS | 426 | O95104 | |
| ERRRTLNKARASRSS | 861 | Q8TB24 | |
| RTRSKSREKRHRHRS | 291 | Q9Y383 | |
| SREKRHRHRSRSSSR | 296 | Q9Y383 | |
| RSSSRSRSRSHQRSR | 306 | Q9Y383 | |
| SRSRSHQRSRHSSRD | 311 | Q9Y383 | |
| HQRSRHSSRDRSRER | 316 | Q9Y383 | |
| HSSRDRSRERSKRRS | 321 | Q9Y383 | |
| FKHSERRRRSQRLAT | 406 | A8MW92 | |
| HRSRSRSKEGRRHES | 61 | Q7L4I2 | |
| ERKSSRGRSHSRSRS | 116 | Q7L4I2 | |
| HSRSRSRSRHSRKSR | 191 | Q08170 | |
| KRFTRSDELQRHRRT | 686 | Q02446 | |
| SGSRRKRRHRSRSSK | 216 | A6NNA2 | |
| RHSEAEATRARRRSR | 541 | A6NNA2 | |
| RRRSREREHQTSQDS | 91 | O75069 | |
| RSRSKSETKSRHRTR | 1316 | P30414 | |
| SHSRRKRSQSKHRSR | 206 | Q8WXA9 | |
| SHNRSRSRQKDRRRS | 221 | Q8WXA9 | |
| RERRKSRSRSHSRDK | 246 | Q8WXA9 | |
| SRSRSHSRDKRKDTR | 251 | Q8WXA9 | |
| RRRSDSLKESRHRRF | 131 | Q8WXF0 | |
| ADRHKRERSRARRAS | 596 | Q02040 | |
| SRRSHSKDRHRRERS | 646 | Q02040 | |
| SASRKHSRHRRRSER | 666 | Q02040 | |
| TRQRRSSGHRNDTAR | 551 | P60852 | |
| TSRSLRLSHKTRRTR | 26 | Q13009 | |
| HSRSRSPNKARDRSR | 401 | B3KS81 | |
| RSRSPNKARDHSRSR | 451 | B3KS81 | |
| HSRSRSPNKARDRSR | 461 | B3KS81 | |
| RDRSRSRSPSKERDH | 471 | B3KS81 | |
| QSRSSSKERDHRRSR | 511 | B3KS81 | |
| RRQSRSSSEERDHSR | 581 | B3KS81 | |
| RERNHKPSRSFSRSR | 141 | P84103 | |
| KHRNRSFSRSKSNSR | 166 | O75494 | |
| HSRERGRRSRSTSKT | 296 | Q05519 | |
| TRRIKSCRFHRRRSS | 431 | A6NEE1 | |
| SSSSSRRERHRGKHR | 621 | Q9H7N4 | |
| RRSSSRSHSRVRAIA | 1336 | O75038 | |
| RSHSRVRAIASRARQ | 1341 | O75038 | |
| SSPVRRERKRSHSRS | 186 | Q8IYB3 | |
| RSRSRSRNAGKRSRS | 436 | Q5VTL8 | |
| RSRSKSRSRSRRHSH | 51 | Q13595 | |
| KRNRSESSRSSRRHS | 506 | Q96N46 | |
| RKRDRDERDRSRHSS | 166 | Q92620 | |
| DERDRSRHSSRSERD | 171 | Q92620 | |
| DSERSHRLSTRDRDR | 241 | Q92620 | |
| KKHRSRSRSRERRSR | 191 | Q01081 | |
| SERERRRSRSHSRSE | 396 | Q9BYW2 | |
| SHSRSSERSSHRRTR | 116 | Q96IZ7 | |
| SERSSHRRTRSRSRD | 121 | Q96IZ7 | |
| HRKRGRSRSSDSRSQ | 591 | Q9NS56 | |
| RSRSSDHGKRRSRSR | 671 | Q9NS56 | |
| RHRSRSLSSNRSRTA | 766 | Q9NS56 | |
| ENRHRKRSHSRSRSR | 21 | P26368 | |
| KRSHSRSRSRDRKRR | 26 | P26368 | |
| HGRSRRREQSSSRNS | 496 | P17098 | |
| RSQSRRSHRSRSQSS | 441 | Q15695 | |
| RSHRSRSQSSSRCRS | 446 | Q15695 | |
| HRRSTRARSRQERAS | 1171 | Q9Y3S1 | |
| RHTPARSRSKEDSRR | 31 | P62995 | |
| ESHSSRRRNRHSKSK | 451 | P48651 | |
| TSKSRERHNSRSRGR | 411 | Q15696 | |
| SRERKRKRSSSRDNR | 1901 | P18583 |